# FDA Inspection 797920 - Novartis Pharmaceuticals Corporation - August 23, 2012

Source: https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/1ac88356-fd20-4105-954d-9ad888e1df70
Source feed: FDA_Inspections

> FDA Inspection 797920 for Novartis Pharmaceuticals Corporation on August 23, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 797920
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2012-08-23
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1276202 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/3303ef9b-e9df-40c1-ae82-b9aa34bb6c57)
- [FDA Inspection 1276202 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/d76eeb82-f498-4fa6-9c50-25c0625a0d59)
- [FDA Inspection 1263198 - 2025-03-03](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/ad5f75b3-032d-4614-ab72-4090e385dec1)
- [FDA Inspection 1263198 - 2025-03-03](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/065307bf-8ec2-419d-a241-59ae20580926)
- [FDA Inspection 1257911 - 2024-11-19](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/be756448-ed2f-448d-a977-168d3e2f3ff8)

Company: https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/aa4c85c1-794a-407a-8eb3-8802c196795b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c